Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None

Similar documents
Undifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD

Rheumatology Primer: What Labs and When

Clinical Laboratory. 14:41:00 Complement Component 3 50 mg/dl Oct-18

Test Name Results Units Bio. Ref. Interval

Clinical Laboratory. [None

Budsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital

Is it Autoimmune or NOT! Presented to AONP! October 2015!

Objectives. Joint Pain. Case 1. Rheumatology for the Primary MD (Not just your grandmother s disease) 12/4/2010

Rheumatology 101 A Pediatrician s Guide

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval

The Power of the ANA. April 2018 Emily Littlejohn, DO MPH

What will we discuss today?

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.

Scott Vogelgesang, MD Division of Rheumatology/Immunology University of Iowa

Autoimmune (AI) Disorders

High Impact Rheumatology

Interpreting Rheumatologic Lab Tests

Clinical Laboratory. 14:42:00 SSA-52 (Ro52) (ENA) Antibody, IgG 1 AU/mL [0-40] Oct-18

Essential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT

SLE-key Case Studies

APPROACH TO PATIENTS WITH POLYARTHRALGIA

Tools to Aid in the Accurate Diagnosis of. Connective Tissue Disease

Autoimmune diseases. SLIDE 3: Introduction to autoimmune diseases Chronic

Development of SLE among Possible SLE Patients Seen in Consultation: Long-Term Follow-Up. Disclosures. Background. Evidence-Based Medicine.

NATIONAL LABORATORY HANDBOOK. Laboratory Testing for Antinuclear antibodies

Autoantibodies panel ANA

Rheumatologic Lab Tests

Insights into the DX of Pediatric SLE

When to Suspect Autoimmune Disease. Michael Cho, MD, Group Health

Autoantibodies in the Idiopathic Inflammatory Myopathies

Rheumatology Educational Goals & Objectives

INTERPRETATION OF LABORATORY TESTS IN RHEUMATIC DISEASE

Rhematologic serum testing is: Before request serologic tests, ANCA associated antigens c-anca: most commonly against the proteinase 3 (PR-3)

Advances in Laboratory Testing for Rheumatic Diseases Updates in Testing for Rheumatic Diseases. The ABIM s view of rheumatologic lab testing

Reporting Autoimmune Diseases in Hematopoietic Stem Cell Transplantation

PAEDIATRIC VASCULITIS

LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS

MANAGING THE PATIENT WITH POSITIVE ANA

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center

Multidisciplinary Diagnosis in Action: Challenging Case Presentations

Assays. New. New. Combinations. Possibilities. Patents: EP , AU

Jeopardy. What s the rash? $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400

Systemic Lupus Erythematosus

Vasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis

Diagnostic Tests in Rheumatic Disease: What s Old, What s New & What s Useful? COPYRIGHT

Disclosures. Clinical Approach: Evaluating CTD-ILD for the pulmonologist. ILD in CTD. connective tissue disease or collagen vascular disease

Lupus and Friends Perspectives on common syndromes and Primary care responses

THICK AS THIEVES: A CURIOUS CASE OF SJOGREN S SYNDROME. Sophie Wojcik, Dr Murray Baron PGY5 Rheumatology McGill University Friday May 11 th 2018

Comparison of Performance of ELISA with Indirect Immunofluoresence for the Testing of Antinuclear Antibodies

Interpretation of Immunological Investigations in Clinical Practice

1 Eileen Ginsburg, DNP, FNP-BC, ARNP 10/10/2018

SLE and the Antiphospholipid Syndrome

ArLAR 2018, the Pan Arab Rheumatology Conference in conjunction with the 1st OSR meeting 23 to 25 February 2018, Muscat, Oman.

University of Pretoria

Rheumatologic Testing in Primary Care

LAB TESTING IN RHEUMATOLOGY DR. PHILIP A. BAER SEACOURSES ASIA CME DECEMBER 2017

Advances in Autoantibody Testing & Clinical Applications

Patient #1. Rheumatoid Arthritis. Rheumatoid Arthritis. 45 y/o female Morning stiffness in her joints >1 hour

Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward

SCLERODERMA OVERLAP SYNDROME: A CASE REPORT Diwakar K. Singh 1, Nataraju H. V 2

9/13/2015. Nothing to disclose

Clinicopathological Conference

.,Dr Ali Alkazzaz Babylon collage of medicine 2016

Alida R Harahap & Farida Oesman Department of Clinical Pathology Faculty of Medicine, University of Indonesia

Rheumatoid arthritis and Psoriatic arthritis: a guide for Primary Care. Nina Flavin, MD Rheumatology Confluence Health April 13 th, 2018

Cutaneous manifestations and systemic correlation in patients with lupus erythematosus and its subsets: a study of 40 cases

Mary Derlacki, FNP. No financial relationships to disclose. Office Rheumatology for the Nurse Practitioner. Rheumatoid Arthritis

Manifestations and Presentations of Collagen Vascular Diseases. Joseph LaConti, M.D., Ph.D. Center for Arthritis and Rheumatic Diseases Miami, FL

Myositis and Your Lungs

9/25/2013 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Annual Rheumatology & Therapeutics Review for Organizations & Societies

My Fingers are Blue: Benign or Worrisome? Joke Dehoorne, dienst kinderreumatologie, UZ Gent Kinderartsenvergadering 21/2/2017

Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population

Rheumatology Labs for the General Internist. Adam J Grunbaum DO FACOI FACR ACOI Annual Convention and Scientific Sessions 2018

Cases I have Learned From. Jeffrey P. Callen, MD Professor of Medicine (Dermatology) University of Louisville

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

ANA testing can now be ordered in several ways, depending on the clinical circumstances:

Marilina Tampoia, MD; Vincenzo Brescia, MD; Antonietta Fontana, MD; Antonietta Zucano, PhD; Luigi Francesco Morrone, MD; Nicola Pansini, MD

This month, we are very pleased to introduce some new tests for Scleroderma as well as some test changes to our existing scleroderma tests/panels.

Mechanisms of Autontibodies

ANA and Antibody Series Changes in ANA and Antibody Levels in Scleroderma

When is it Rheumatoid Arthritis When to Refer

How to interpret and order rheumatology tests

Demystifying. Systemic Lupus Erythematosus: Signs and Symptoms for Early Recognition. Teaching Fellows in Lupus Project

Case Presentation VASCULITIS. Case Presentation. Case Presentation. Vasculitis

Guidelines for Immunologic Laboratory Testing in the Rheumatic Diseases: Anti-Sm and Anti-RNP Antibody Tests

Case Presentation. Rafid Asfar, MD

LUPUS. and Associated Conditions LUPUSUK 2018

Rheumatology for the Nurse Practitioner. Mary Derlacki, FNP Eugene Rheumatology

Conflict of Interest. Systemic Lupus Erythematosus and the Antiphospholipid Syndrome Bonnie L. Bermas, MD Brigham and Women s Hospital.

VASCULITIS. Case Presentation. Case Presentation

DISCUSSION BY: Dr M. R. Shakeebi, MD, Rheumatologist

ACP Rheumatology Pearls. Adam Q Carlson MD Assistant Professor UVA Rheumatology

Supplementary Figure Legends

Comparison of indirect immunofluorescence and line immunoassay for autoantibody detection

Introduce the important components of the immune system Show how they interact & protect the body

Medical Immunology Practice Questions-2016 Autoimmunity + Case Studies

Lupus. Fast facts. What is lupus? What causes lupus? Who gets lupus?

Department of Paediatrics Clinical Guideline

Transcription:

Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies Sarah Goglin MD Assistant Professor of Medicine Division of Rheumatology Disclosures None 1 [footer text here]

Objectives By the end of this talk, you will: Have a basic understanding of the major categories of systemic autoimmune disease Develop an approach to the history and physical exam of a patient with suspected rheumatic disease Develop an approach to ordering and interpreting rheumatologic serologies Categories of rheumatic disease Connective tissue disease Antiphospholipid syndrome IgG4- related disease Vasculitis Inflammatory arthritis Sarcoidosis 2 [footer text here]

Case 1 Case 1 54 yo woman with hypothyroidism presents with slowly progressive symmetric numbness and paresthesias affecting her distal lower extremities ROS: +joint pain in the small joints of her fingers, +dry eyes when she wears her contacts ANA 1:160 diffuse, SSA 24 (<20) 3 [footer text here]

Case 1 What is the most appropriate next step? A. Refer her to rheumatology for likely diagnosis of SLE B. Check a Hba1c and start gabapentin for her neuropathic symptoms C. Refer to oral medicine for minor salivary gland biopsy to confirm suspected diagnosis of Sjogren s syndrome D. Start prednisone for possible immune-mediated neuropathy Inflammatory versus non-inflammatory pain Inflammatory Non-inflammatory Morning stiffness + - Change with activity Improves Worsens Constitutional symptoms + - ESR/CRP Elevated Normal Extra-articular manifestations + -** Rheumatoid arthritis Osteoarthritis Fibromyalgia 4 [footer text here]

But what about her facial rash? Acute cutaneous lupus Indurated Overlying scale Tends to occur in photo-exposed areas Spares nasolabial folds 5 [footer text here]

Back to Case 1 Erythrotelangiectatic rosacea w a few small acneiform papules Not indurated No scale Doesn t spare nasolabial folds Not acute cutaneous lupus! Subacute cutaneous lupus 6 [footer text here]

Discoid lupus But what about her positive ANA and SSA? 7 [footer text here]

Causes of positive ANA ANA is not specific for SLE; found in low titers in 10-20% of the healthy population Also seen in other autoimmune diseases, infections, malignancies Autoimmune thyroid disease (ATD) is a well known cause of a positive ANA - Up to 50% of patients with ATD have a positive ANA - Up to 15% have been found to have a positive SSA Case 1 What is the most appropriate next step? A. Refer her to rheumatology for likely diagnosis of SLE No, although she has a positive ANA, she has no other features to suggest a diagnosis of SLE. Her facial rash is rosacea. B. Check a Hba1c and start gabapentin for her neuropathic symptoms Standard work up and treatment for peripheral neuropathy is indicated based on lack of evidence of an underlying systemic disease. C. Refer to oral medicine for minor salivary gland biopsy to confirm suspected diagnosis of Sjogren s syndrome No, although she has a low titer SSA antibody, this can be explained by autoimmune thyroid disease and she lacks the severe Sicca symptoms that are typical for patients with Sjogren s syndrome. D. Start prednisone for possible immune-mediated neuropathy No, there is nothing to support a systemic autoimmune disease as the cause of her neuropathy. 8 [footer text here]

Case 2 Case 2 37 yo woman transferred to UCSF with altered mental status, progressive urinary retention, and bilateral lower extremity weakness MRI spine consistent with transverse myelitis 9 [footer text here]

Case 2 WBC 3.5 (ALC 0.5), Hb 9, Hct 26.7, Plt 91 ANA screen negative at transferring hospital C3 41 (71-159 mg/dl), C4 2.8 (13-30 mg/dl) Case 2 What is the best next step? A. Recheck ANA B. Check ANCA C. Consult hematology for evaluation of pancytopenia D. Start empiric RIPE therapy for possible TB myelitis 10 [footer text here]

Case 2 ANA 1:80 diffuse Anti-dsDNA 197 (<20) Sm, RNP, SSA, SSB negative NMO antibody negative Diagnosed with SLE-associated longitudinally extensive transverse myelitis Types of connective tissue disease Myositis Scleroderma Systemic lupus Connective Tissue Diseases Mixed connective tissue disease Sjogren If you suspect a connective tissue disease, an ANA alone is the appropriate first screening autoantibody test 11 [footer text here]

Pitfalls of ANA testing ANA by indirect immunofluorescence (IIF) ANA by ELISA Non-IIF assays have increased specificity but decreased sensitivity for ANA -> ANA negative lupus If ANA is negative and clinical suspicion is high, check by another assay ANA testing Pattern Nuclear antigen Clinical associations Homogenous Double-stranded DNA SLE Diffuse Speckled Histone Topoisomerase I Extractable nuclear antigens (Sm, RNP) Ro-SSA**/La-SSB Other Drug-induced lupus SLE Systemic sclerosis MCTD SLE Sjogren s syndrome Poly/dermatomyositis Various autoimmune diseases Infection Neoplasia Nucleolar RNA-associated antigens Systemic sclerosis Peripheral Double-stranded DNA SLE Centromere Centromere Limited systemic sclerosis Only check subserologies if ANA is positive by IIF **SSA is exception Don t repeat the ANA once you know it is positive it doesn t track with disease activity 12 [footer text here]

ANA subserologies % Autoantibodies % in Autoantibodies Patients with Rheumatic in Patients with Diseases Rheumatic Diseases ease ANA Disease & RF ANA dsdna & Sm RF dsdna Ro La Sm Scl-70 Ro Cent La Scl-70 Jo RNP Cent Jo RN Pattern Pattern 95 99 SLE 20 50 70 95 99 30 20 35 50 7015 30 0 35 015 00 30 50 0 0 30 D, S, N D, S, N 15 35D RA 85 15 35D <5 85 0 10 <5 5 0 0 10 05 00 100 0 1 gren s >90 Sjögren s 75 >90 <5 75 0 55 <5 40 0 0 55 040 00 150 0 1 D, S D, S use >90 Diffuse 30 >90 0 30 0 5 0 1 0 40 5 <5 1 040 30 <5 0 3 N, S, SSc D N, S, D ted >90 Limited 30 >90 0 30 0 5 0 1 0 <5 5 701 0 <5 3070 0 3 S, N, SSc D S, N, D DM 75 95 PM-DM 33 75 95 0 33 0 0 0 0 0 10 0 00 25 10 00 25 0 TD 95 99 MCTD 50 95 99 0 50 0 <5 0 <5 0 0 <5 0 <5 00 1000 0 10 S, D S, D Wallace et al. Pocket Medicine 5 th edition 13 [footer text here]

Case 2 What is the best next step? A. Recheck ANA Yes! Clinical suspicion for SLE is high, so check ANA by IIF. B. Check ANCA No, there is nothing to suggest small vessel vasculitis as the cause of her presentation. C. Consult hematology for evaluation of pancytopenia No, her cytopenias are likely due to SLE. D. Start empiric RIPE therapy for possible TB myelitis No, there are many red flags for lupus myelitis here and she lacks any risk factors or other clinical evidence of TB. Case 3 14 [footer text here]

Case 3 71 yo woman with adult-onset asthma presents with acute onset right hand weakness and numbness, followed by left hand weakness, and subsequent bilateral foot drop over the period of a month Also concomitantly developed digital ischemia ROS: +40 lb weight loss, +oral ulcers, +uncontrolled asthma symptoms Case 3 Lessons for the Practicing Neurologist 15 [footer text here]

Case 3 WBC 20.2 (absolute eos 9.6), Hb 11, Hct 33.3, Plt 490 ESR >100 C3 and C4 are normal UA with 20-50 RBCs, 2+ protein Case 3 What is the best next step? A. Order an ANCA B. Order a conventional mesenteric angiogram C. Order antiphospholipid antibodies D. Order cryoglobulins 16 [footer text here]

Vasculitis schema by vessel size Diagnostic schema for vasculitis Imboden et al. Current Diagnosis and Treatment Rheumatology 3 rd edition 17 [footer text here]

Small vessel vasculitis Cutaneous manifestations Palpable purpura Medium vessel vasculitis Cutaneous manifestations Ulcers Nodules 18 [footer text here]

Small vessel vasculitis Pulmonary manifestations Nodules (GPA) Diffuse alveolar hemorrhage Asthma (severe, adult-onset), fleeting infiltrates = EGPA Medium vessel vasculitis Pulmonary manifestations None! 19 [footer text here]

Small versus medium vessel vasculitis Renal manifestations Small vessel vasculitis Clinical features: HTN, proteinuria, hematuria, renal failure (but not always, esp early in course) Medium vessel vasculitis Clinical features: HTN, occasionally hematuria, NO PROTEINURIA Case 3 What is the best next step? A. Order an ANCA Yes, you are concerned for EGPA due to eosinophilia, asthma, and signs of small-med vessel vasculitis (digital necrosis, mononeuritis multiplex, hematuria/proteinuria suggesting GN) B. Order a conventional mesenteric angiogram This would be the appropriate test if you suspected PAN. Although mononeuritis and digital ischemia can be seen in PAN, there are many features of this case that are not consistent with this diagnosis. C. Order antiphospholipid antibodies No, hypercoagulability alone would not explain this presentation. D. Order cryoglobulins No, the normal complement levels (esp C4) essentially excludes cryo vasculitis. In addition, this would not explain eos and asthma. 20 [footer text here]

Conclusions Always use your history, physical exam, and basic labs to guide autoantibody serologic testing Know the limitations of lab tests When considering a diagnosis of a systemic rheumatic disease, use the extra-neurologic organ involvement to help narrow differential diagnosis and direct work up Don t hesitate to call your friendly neighborhood rheumatologist! 21 [footer text here]